Fera Pharmaceuticals Announces Launch of a New Ophthalmic Anti-Infective

NEW YORK--(BUSINESS WIRE)--Fera Pharmaceuticals is pleased to announce the launch of Sulfacetamide Sodium Ophthalmic Ointment USP, 10%.

Indicated for superficial ocular infections, including conjunctivitis, Sulfacetamide, in ointment form, will be an important addition to physicians’ treatment armamentarium.

MORE ON THIS TOPIC